scholarly article | Q13442814 |
P2093 | author name string | Qin Li | |
Jia Chen | |||
Ying Xiong | |||
Catherine C Y Chang | |||
Ming Zhu | |||
Xiaowei Zhang | |||
Baoliang Song | |||
Boliang Li | |||
Dongqing Guo | |||
Guangjing Hu | |||
Jiajia Xu | |||
Tayuan Chang | |||
Xiaonan Zhao | |||
P2860 | cites work | Knockdown of ACAT-1 reduces amyloidogenic processing of APP | Q24301804 |
Enhancement of human ACAT1 gene expression to promote the macrophage-derived foam cell formation by dexamethasone | Q24302908 | ||
Angiotensin II upregulates acyl-CoA:cholesterol acyltransferase-1 via the angiotensin II Type 1 receptor in human monocyte-macrophages | Q24310188 | ||
Molecular cloning and functional expression of human acyl-coenzyme A:cholesterol acyltransferase cDNA in mutant Chinese hamster ovary cells | Q24318507 | ||
RNA secondary structures located in the interchromosomal region of human ACAT1 chimeric mRNA are required to produce the 56-kDa isoform | Q24601853 | ||
Phytochelatins are synthesized by two vacuolar serine carboxypeptidases in Saccharomyces cerevisiae | Q27931537 | ||
Immunological quantitation and localization of ACAT-1 and ACAT-2 in human liver and small intestine | Q28137924 | ||
Human acyl-CoA:cholesterol acyltransferase-1 (ACAT-1) gene organization and evidence that the 4.3-kilobase ACAT-1 mRNA is produced from two different chromosomes | Q28140941 | ||
Alzheimer's disease: the cholesterol connection | Q28186482 | ||
Roles of acyl-coenzyme A:cholesterol acyltransferase-1 and -2 | Q28189085 | ||
Acyl-coenzyme A:cholesterol acyltransferase | Q28245277 | ||
Leptin modulates ACAT1 expression and cholesterol efflux from human macrophages | Q28252737 | ||
Human acyl-coenzyme A:cholesterol acyltransferase 1 (acat1) sequences located in two different chromosomes (7 and 1) are required to produce a novel ACAT1 isoenzyme with additional sequence at the N terminus | Q28277913 | ||
Insulin induces human acyl-coenzyme A: cholesterol acyltransferase1 gene expression via MAP kinases and CCAAT/enhancer-binding protein α | Q28288583 | ||
Peptides containing the RERMS sequence of amyloid beta/A4 protein precursor bind cell surface and promote neurite extension | Q28513050 | ||
THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM | Q29391553 | ||
BACE1: the beta-secretase enzyme in Alzheimer's disease | Q33202614 | ||
Cell cholesterol efflux: integration of old and new observations provides new insights. | Q33605655 | ||
Intracellular cholesterol trafficking: role of the NPC1 protein | Q33944786 | ||
ACAT inhibition and amyloid beta reduction | Q34052308 | ||
Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process | Q34110227 | ||
Human acyl-CoA:cholesterol acyltransferase 2 gene expression in intestinal Caco-2 cells and in hepatocellular carcinoma. | Q34651211 | ||
Cholesterol and the biology of Alzheimer's disease. | Q35625391 | ||
Human acyl-CoA:cholesterol acyltransferase (ACAT) and its potential as a target for pharmaceutical intervention against atherosclerosis | Q36414556 | ||
Production of ACAT1 56-kDa isoform in human cells via trans-splicing involving the ampicillin resistance gene | Q37064656 | ||
Acat1 knockdown gene therapy decreases amyloid-β in a mouse model of Alzheimer's disease | Q37073099 | ||
ACAT as a drug target for Alzheimer's disease | Q37103056 | ||
Acyl-coenzyme A:cholesterol acyltransferases | Q37264194 | ||
Inhibition of acyl-coenzyme A: cholesterol acyl transferase modulates amyloid precursor protein trafficking in the early secretory pathway | Q37415858 | ||
Intracellular cholesterol homeostasis and amyloid precursor protein processing | Q37715386 | ||
Cellular membrane fluidity in amyloid precursor protein processing. | Q38189670 | ||
The role of endoplasmic reticulum in amyloid precursor protein processing and trafficking: implications for Alzheimer's disease. | Q38212139 | ||
MiR-9 reduces human acyl-coenzyme A:cholesterol acyltransferase-1 to decrease THP-1 macrophage-derived foam cell formation | Q39096724 | ||
Ghrelin inhibits foam cell formation via simultaneously down-regulating the expression of acyl-coenzyme A:cholesterol acyltransferase 1 and up-regulating adenosine triphosphate-binding cassette transporter A1. | Q39800594 | ||
Human ACAT1 gene expression and its involvement in the development of atherosclerosis | Q40361549 | ||
Acyl-coenzyme A: cholesterol acyltransferase modulates the generation of the amyloid beta-peptide | Q40777105 | ||
Synergistic transcriptional activation of human Acyl-coenzyme A: cholesterol acyltransterase-1 gene by interferon-gamma and all-trans-retinoic acid THP-1 cells | Q40799447 | ||
Cleavage of Alzheimer's amyloid precursor protein by alpha-secretase occurs at the surface of neuronal cells | Q40939308 | ||
Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein | Q41226800 | ||
Secreted forms of beta-amyloid precursor protein protect against ischemic brain injury | Q41451125 | ||
Cleavage of amyloid beta peptide during constitutive processing of its precursor | Q41852594 | ||
The survival of rat cerebral cortical neurons in the presence of trophic APP peptides | Q48129570 | ||
Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor protein | Q48342880 | ||
Soluble amyloid precursor protein alpha reduces neuronal injury and improves functional outcome following diffuse traumatic brain injury in rats | Q48541352 | ||
Analysis of the distribution of cholesterol in the intact cell | Q50169842 | ||
The optional long 5'-untranslated region of human ACAT1 mRNAs impairs the production of ACAT1 protein by promoting its mRNA decay. | Q51782635 | ||
The ACAT inhibitor CP-113,818 markedly reduces amyloid pathology in a mouse model of Alzheimer's disease. | Q52086849 | ||
Human Acyl-CoA:Cholesterol Acyltransferase-1 Is a Homotetrameric Enzyme in Intact Cells andin Vitro | Q61898959 | ||
Rapid intracellular transport of LDL-derived cholesterol to the plasma membrane in cultured fibroblasts | Q68727843 | ||
19 Receptor-mediated endocytosis of low-density lipoprotein in cultured cells | Q70193016 | ||
Immunodepletion experiments suggest that acyl-coenzyme A:cholesterol acyltransferase-1 (ACAT-1) protein plays a major catalytic role in adult human liver, adrenal gland, macrophages, and kidney, but not in intestines | Q77150716 | ||
U18666A inhibits intracellular cholesterol transport and neurotransmitter release in human neuroblastoma cells | Q78109239 | ||
P433 | issue | 12 | |
P304 | page(s) | 951-959 | |
P577 | publication date | 2015-10-15 | |
P1433 | published in | Acta Biochimica et Biophysica Sinica | Q2183997 |
P1476 | title | ACAT1 regulates the dynamics of free cholesterols in plasma membrane which leads to the APP-α-processing alteration | |
P478 | volume | 47 |
Q39180626 | Cellular Cholesterol Homeostasis in Alzheimer's Disease |
Q45305840 | Intracellular Cholesterol Trafficking and Impact in Neurodegeneration |
Q38735980 | Low-level expression of human ACAT2 gene in monocytic cells is regulated by the C/EBP transcription factors |
Q50299793 | SOAT1,2 transfer acyl group to CHOL forming CHEST |
Q38735984 | The ACAT2 expression of human leukocytes is responsible for the excretion of lipoproteins containing cholesteryl/steryl esters |
Search more.